121 related articles for article (PubMed ID: 25003253)
1. Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
Kim JY; Alam F; Chung SW; Park J; Jeon OC; Kim SY; Son WC; Byun Y
Anticancer Drugs; 2014 Oct; 25(9):1061-71. PubMed ID: 25003253
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
3. High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives.
Park JW; Jeon OC; Kim SK; Al-Hilal TA; Jin SJ; Moon HT; Yang VC; Kim SY; Byun Y
J Control Release; 2010 Dec; 148(3):317-26. PubMed ID: 20869408
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell.
Wang Z; Fuentes CF; Shapshay SM
Laryngoscope; 2002 May; 112(5):839-43. PubMed ID: 12150615
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of p53 and mitochondrial signaling pathway in apoptosis by a combination of COX-2 inhibitor, Celecoxib and Dolastatin 15, a marine mollusk linear peptide in experimental colon carcinogenesis.
Piplani H; Vaish V; Rana C; Sanyal SN
Mol Carcinog; 2013 Nov; 52(11):845-58. PubMed ID: 22623379
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib.
Park K; Yang JH; Choi Y; Lee C; Kim SY; Byun Y
J Control Release; 2005 May; 104(1):167-79. PubMed ID: 15866343
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of arylamine-induced colorectal aberrant crypts.
Feng Y; Neale JR; Doll MA; Hein DW
Exp Biol Med (Maywood); 2008 Jan; 233(1):71-5. PubMed ID: 18156308
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
13. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
14. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention in colorectal neoplasias: what is practical and feasible?
Ricciardiello L; Roda E; Bazzoli F
Dig Dis; 2002; 20(1):70-2. PubMed ID: 12145422
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
Kismet K; Akay MT; Abbasoglu O; Ercan A
Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris RE; Alshafie GA; Abou-Issa H; Seibert K
Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
[TBL] [Abstract][Full Text] [Related]
18. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis proposes alternative pathways for the mechanism by which celecoxib selectively inhibits the growth of transformed but not normal enterocytes.
Sagiv E; Rozovski U; Kazanov D; Liberman E; Arber N
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6807-15. PubMed ID: 18006783
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib and melatonin in prevention of female rat mammary carcinogenesis.
Orendas P; Kassayova M; Kajo K; Ahlers I; Kubatka P; Bojkova B; Pec M; Ahlersova E
Neoplasma; 2009; 56(3):252-8. PubMed ID: 19309229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]